Tower Research Capital (TRC)’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.27K Sell
1,155
-11,587
-91% -$62.9K ﹤0.01% 4116
2025
Q1
$35.5K Buy
12,742
+6,963
+120% +$19.4K ﹤0.01% 2483
2024
Q4
$19.7K Buy
5,779
+9
+0.2% +$31 ﹤0.01% 3195
2024
Q3
$17K Sell
5,770
-245
-4% -$720 ﹤0.01% 3340
2024
Q2
$20.5K Buy
6,015
+2,436
+68% +$8.28K ﹤0.01% 3754
2024
Q1
$10.8K Buy
3,579
+111
+3% +$336 ﹤0.01% 3638
2023
Q4
$14.6K Sell
3,468
-2,122
-38% -$8.93K ﹤0.01% 3877
2023
Q3
$38.2K Sell
5,590
-3,346
-37% -$22.9K ﹤0.01% 2795
2023
Q2
$93.1K Buy
8,936
+7,402
+483% +$77.1K ﹤0.01% 2057
2023
Q1
$11K Sell
1,534
-4,674
-75% -$33.5K ﹤0.01% 4198
2022
Q4
$37K Buy
6,208
+4,589
+283% +$27.4K ﹤0.01% 2558
2022
Q3
$13K Sell
1,619
-2,211
-58% -$17.8K ﹤0.01% 4261
2022
Q2
$52K Buy
3,830
+2,714
+243% +$36.8K ﹤0.01% 2836
2022
Q1
$21K Sell
1,116
-2,415
-68% -$45.4K ﹤0.01% 3479
2021
Q4
$121K Buy
3,531
+3,253
+1,170% +$111K ﹤0.01% 2107
2021
Q3
$15K Sell
278
-7,448
-96% -$402K ﹤0.01% 3966
2021
Q2
$567K Buy
+7,726
New +$567K 0.01% 1082